By Qin Liu, et al. originally published January 26, 2022 in BMJ Gut. Abstract Background Long-term complications after COVID-19 are common, but the potential cause for persistent symptoms after viral clearance remains unclear. Objective To investigate...
Results can help anticipate the scale of future health complications and improve planning for use of healthcare resources Almost a third (32 of every 100) of older adults infected with covid-19 in 2020 developed at least one new condition that required medical...
By Peter Doshi, senior editor British Medical Journal with comments by Mark Bricca, ND Scientific integrity and ethics demand that data concerning the largest worldwide clinical trial ever be made available for analysis by scientists and researchers outside of pharma...
Results confirm that protection wanes with time and suggest a third (booster) dose might be warranted A study published by The BMJ today finds a gradual increase in the risk of covid-19 infection from 90 days after receiving a second dose of the...
By Yun Kit Yeoh, et al. with Commentary by Mark Bricca, ND Below is a paper that explores the relationships between GI microbiota, Covid-19 severity, and long-Covid.Not surprisingly, worse outcomes are associated with more pathogenic GI microbial strains and less...
Published September 13, 2021 in the British Medical Journal by Jennifer Block The US CDC estimates that SARS-CoV-2 has infected more than 100 million Americans, and evidence is mounting that natural immunity is at least as protective as vaccination. Yet public health...
June 13, 2021 ~ TrialSite News Study Reveals Plant-based Diet Lowers Risk of Moderate to Severe COVID-19 Researchers from a number of prominent institutions sought to answer the question: what, if anything, does diet have to do with the fact that when it comes to...
https://www.bmj.com/content/373/bmj.n747 Originally published by: BMJ Author: Bibi-Aisha Wadvalla Date: 4/1/2021 Categories: Integrative Therapies,Treatment,Ivermectin